Fundraising FoxLyncbio
1 known investors
Find your way into Lyncbio
Sign up to see every warm intro you have to Lyncbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lyncbio team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lync Bio develops fourth-generation SMART ADC (antibody-drug conjugate) technology for oncology, leveraging proprietary dual-target conjugate design and payload engineering to improve tumor coverage, cellular response, and manufacturability.
Investors · 1
Frequently asked questions
- What does Lyncbio do?
- Lync Bio develops fourth-generation SMART ADC (antibody-drug conjugate) technology for oncology, leveraging proprietary dual-target conjugate design and payload engineering to improve tumor coverage, cellular response, and manufacturability.
- Who are Lyncbio's investors?
- Lyncbio's investors include Pan-Lin Capital.